Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 11;15(5):e04779.
doi: 10.2903/j.efsa.2017.4779. eCollection 2017 May.

Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow-on formula manufactured from protein hydrolysates

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Dominique Turck, Jean-Louis Bresson, Barbara Burlingame, Tara Dean, Susan Fairweather-Tait, Marina Heinonen, Karen Ildico Hirsch-Ernst, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Monika Neuhäuser-Berthold, Grażyna Nowicka, Kristina Pentieva, Yolanda Sanz, Anders Sjödin, Martin Stern, Daniel Tomé, Henk Van Loveren, Marco Vinceti, Peter Willatts, Mary Fewtrell, Hildegard Przyrembel, Ariane Titz, Silvia Valtueña Martínez

Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow-on formula manufactured from protein hydrolysates

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) et al. EFSA J. .

Abstract

Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to provide scientific and technical guidance for the preparation and presentation of applications for authorisation of infant and/or follow-on formula manufactured from protein hydrolysates. This guidance document addresses the information and data to be submitted to EFSA on infant and follow-on formulae manufactured from protein hydrolysates with respect to the safety and suitability of the specific formula and/or the formula's efficacy in reducing the risk of developing allergy to milk proteins. The guidance will be further reviewed and updated with the experience gained from the evaluation of specific applications for authorisation, and in the light of future Community guidelines and legislation. The NDA Panel endorsed a draft of this scientific opinion on 14 December 2016 for public consultation. The draft document has been revised and updated according to the comments received, where appropriate.

Keywords: application; follow‐on‐formula; food allergy; guidance; infant formula; milk proteins; protein hydrolysates.

PubMed Disclaimer

References

    1. AAP (American Academy of Pediatrics), 1988. Clinical testing of infant formulas with respect to nutritional suitability for term infants. Report prepared under FDA contract 223‐86‐2117. Available online: http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryIn...
    1. Aggett P, Agostoni C, Axelsson I, Goulet O, Hernell O, Koletzko B, Lafeber HN, Michaelsen KF, Morley R, Rigo J, Szajewska H and Weaver LT and ESPGHAN Committee on Nutrition , 2003. Core data for nutrition trials in infants: a discussion document–a commentary by the ESPGHAN Committee on Nutrition. Journal of Pediatric Gastroenterology and Nutrition, 36, 338–342. - PubMed
    1. Bindslev‐Jensen C, Ballmer‐Weber BK, Bengtsson U, Blanco C, Ebner C, Hourihane J, Knulst AC, Moneret‐Vautrin DA, Nekam K, Niggemann B, Osterballe M, Ortolani C, Ring J, Schnopp C and Werfel T, European Academy of Allergology and Clinical Immunology , 2004. Standardization of food challenges in patients with immediate reactions to foods–position paper from the European Academy of Allergology and Clinical Immunology. Allergy, 59, 690–697. - PubMed
    1. EFSA (European Food Safety Authority), 2010. Application of systematic review methodology to food and feed safety assessments to support decision making. EFSA Journal 2010;8(6):1637, 90 pp. 10.2903/j.efsa.2010.1637 - DOI
    1. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014a. Scientific Opinion on the essential composition of infant and follow‐on formulae. EFSA Journal 2014;12(7):3760, 106 pp. 10.2903/j.efsa.2014.3760 - DOI

LinkOut - more resources